Skip to main content
OTCMKTS:MCURF

Mind Cure Health Stock Forecast, Price & News

$0.27
+0.00 (+0.92 %)
(As of 05/14/2021 03:57 PM ET)
Add
Compare
Today's Range
$0.26
▼
$0.28
50-Day Range N/A
52-Week Range
$0.26
▼
$0.86
Volume174,372 shs
Average Volume417,789 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive MCURF News and Ratings via Email

Sign-up to receive the latest news and ratings for Mind Cure Health and its competitors with MarketBeat's FREE daily newsletter.


About Mind Cure Health

Mind Cure Health Inc. engages in the development, manufacture, and distribution of a branded line of organic and functional mushroom powders. It also operates Mind Cure Health Center, which offers psychedelic-assisted mental health therapy to patients, as well as training to therapists. The company sells its products through online and retail stores in North America. Mind Cure Health Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.

Headlines

Health Insurance: Do you have health cover for Covid treatment?
Health Insurance: Do you have health cover for Covid treatment?
May 11, 2021 |  msn.com
Blue Hive Health, Canadas First Digital Wellness Clinic Opens Expanding Canadians Access to Personalized Mind-Body Healing
Blue Hive Health, Canada's First Digital Wellness Clinic Opens Expanding Canadians Access to Personalized Mind-Body Healing
May 11, 2021 |  markets.businessinsider.com
Maryland Peace of Mind aims to remove stigma associated with mental health
Maryland Peace of Mind aims to remove stigma associated with mental health
May 7, 2021 |  msn.com
Mind Cure Health Inc. (OTCMKTS:MCURF) Sees Significant Decline in Short Interest
Mind Cure Health Inc. (OTCMKTS:MCURF) Sees Significant Decline in Short Interest
May 1, 2021 |  americanbankingnews.com
MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYMs Market Launch, Delivering Mental Wealth
MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM's Market Launch, Delivering Mental Wealth
April 29, 2021 |  finance.yahoo.com
MINDCURE Announces Partnership with SOMA Breath Inc. to License its Breathwork Program and Develop Custom Breathwork for Psychedelic-Assisted Psychotherapies within iSTRYM
MINDCURE Announces Partnership with SOMA Breath Inc. to License its Breathwork Program and Develop Custom Breathwork for Psychedelic-Assisted Psychotherapies within iSTRYM
April 27, 2021 |  finance.yahoo.com
MINDCURE Announces Experienced Finance Executive Michael Wolfe as CFO and appoints Larissa Chaikowsky to its Board of Directors
MINDCURE Announces Experienced Finance Executive Michael Wolfe as CFO and appoints Larissa Chaikowsky to its Board of Directors
April 22, 2021 |  finance.yahoo.com
MINDCURE Partners its iSTRYM Technology with LUCID to Discover and Create Proprietary Music Experiences for Use During Psychedelic-Assisted Therapy Sessions
MINDCURE Partners its iSTRYM Technology with LUCID to Discover and Create Proprietary Music Experiences for Use During Psychedelic-Assisted Therapy Sessions
April 21, 2021 |  finance.yahoo.com
Psychedelics As A Potential Form Of Treatment For Traumatic Brain Injuries
Psychedelics As A Potential Form Of Treatment For Traumatic Brain Injuries
April 20, 2021 |  msn.com
MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors
MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors
April 8, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MCURF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.mindcure.com
Phone888 593 8995
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Medical Sector

1958th out of 2,044 stocks

Biotechnology Industry

140th out of 158 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Mind Cure Health (OTCMKTS:MCURF) Frequently Asked Questions

What stocks does MarketBeat like better than Mind Cure Health?

Wall Street analysts have given Mind Cure Health a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mind Cure Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Mind Cure Health?

Mind Cure Health saw a decline in short interest in April. As of April 15th, there was short interest totaling 118,900 shares, a decline of 35.9% from the March 31st total of 185,500 shares. Based on an average trading volume of 822,900 shares, the short-interest ratio is currently 0.1 days.
View Mind Cure Health's Short Interest.

Who are Mind Cure Health's key executives?

Mind Cure Health's management team includes the following people:
  • Mr. Stephen D. Inouye, Chief Financial Officer and Director
  • Ms. Kelsey Leigh Ramsden, Pres & CEO
  • Mr. Tarik Lebbadi, Chief Operating Officer
  • Mr. Geoff Belair, Chief Technology Officer
  • Dr. Ryan Victor Hartwell, Chief Science Officer & Member of Scientific Advisory Board

Who are some of Mind Cure Health's key competitors?

Some companies that are related to Mind Cure Health include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), 17031 (MYM), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), ADiTx Therapeutics (ADTX), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF) and Almirall (LBTSF).
View all of MCURF's competitors.

What is Mind Cure Health's stock symbol?

Mind Cure Health trades on the OTCMKTS under the ticker symbol "MCURF."

How do I buy shares of Mind Cure Health?

Shares of MCURF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mind Cure Health's stock price today?

One share of MCURF stock can currently be purchased for approximately $0.27.

What is Mind Cure Health's official website?

The official website for Mind Cure Health is www.mindcure.com.

How can I contact Mind Cure Health?

The company can be reached via phone at 888 593 8995.


This page was last updated on 5/15/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.